Yaping Cui
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yaping Cui has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Jiyun Wu
Shaanxi University of Chinese Medicine 712046 Xianyang Shaanxi China
3 shared publicationsYanrong Zhan
Shaanxi University of Chinese Medicine 712046 Xianyang Shaanxi China
3 shared publicationsBozhi Ren
Shaanxi University of Chinese Medicine, Shaanxi, China
1 shared publicationChenxi Xu
Fuling Hospital Affiliated to Chongqing University, Chongqing City, China
1 shared publicationHongbo Ma
Fuling Hospital Affiliated to Chongqing University, Chongqing City, China
1 shared publicationLianhui Liu
Nanjing University of Chinese Medicine 210023 Nanjing Jiangsu China
1 shared publication
Latest Publications
- Open Access
- 1 January 2023
- Published by Francis Academic Press Ltd. in International Journal of Frontiers in Medicine
- Vol. 5 (4)
A meta analysis of TCM syndrome differentiation and treatment combined with biofeedback in the treatment of functional constipation
Objective: To systematically evaluate the efficacy of TCM syndrome differentiation and treatment combined with biofeedback in the treatment of functional constipation. Methods: All the clinical randomized controlled trials (RCTs) of TCM syndrome differentiation and treatment combined with biofeedback in the treatment of functional constipation, which were published in September 2022, were retrieved by computer from CNKI, VIP, Wanfang, The Cochrane Library, Pubmed and Embase and other databases. Use RevMan5.3 software for meta analysis. Results: Totally 937 patients were included in 16 clinical randomized controlled trials. Meta analysis showed that traditional Chinese medicine based on syndrome differentiation and treatment combined with biofeedback treatment for functional constipation had more advantages than conventional biofeedback treatment in terms of effective rate (RR=1.21, 95% CI (1.13, 1.30), Z=5.61, P<0.0001) and improvement of constipation symptom score (SMD=-0.31, 95% CI (-0.53, -0.10), Z=2.82, P=0.005), and the negative rate was higher in balloon ejection test (RR=1.26, 95% CI (1.05, 1.50), Z=2.48, P=0.01), It plays a role in reducing anal systolic pressure (MD=15.56, 95% CI (8.59, 22.53), Z=4.38, P<0.0001), but it has no statistical significance in reducing anal resting pressure (MD=-1.25, 95% CI (-15.75, 13.25), Z=0.17, P=0.87), It also played a very good role in reducing anxiety score (MD=-5.04, 95% CI (-7.16, -2.92), Z=4.66, P<0.00001) and depression score (MD=-5.85, 95% CI (-7.93, -3.77), Z=5.52, P<0.00001), and had a greater advantage in reducing follow-up recurrence rate (RR=0.39, 95% CI (0.25, 0.60), Z=4.27, P<0.0001). In terms of adverse reactions, there was no significant difference between the treatment group and the observation group (P=1.00). Conclusion: TCM syndrome differentiation and treatment combined with biofeedback has more advantages than conventional biofeedback treatment.
- 1 January 2023
- Published by Francis Academic Press Ltd. in International Journal of Frontiers in Medicine
- Vol. 5 (4)
Open AccessA meta analysis of TCM syndrome differentiation and treatment combined with biofeedback in the treatment of functional constipation
Objective: To systematically evaluate the efficacy of TCM syndrome differentiation and treatment combined with biofeedback in the treatment of functional constipation. Methods: All the clinical randomized controlled trials (RCTs) of TCM syndrome differentiation and treatment combined with biofeedback in the treatment of functional constipation, which were published in September 2022, were retrieved by computer from CNKI, VIP, Wanfang, The Cochrane Library, Pubmed and Embase and other databases. Use RevMan5.3 software for meta analysis. Results: Totally 937 patients were included in 16 clinical randomized controlled trials. Meta analysis showed that traditional Chinese medicine based on syndrome differentiation and treatment combined with biofeedback treatment for functional constipation had more advantages than conventional biofeedback treatment in terms of effective rate (RR=1.21, 95% CI (1.13, 1.30), Z=5.61, P<0.0001) and improvement of constipation symptom score (SMD=-0.31, 95% CI (-0.53, -0.10), Z=2.82, P=0.005), and the negative rate was higher in balloon ejection test (RR=1.26, 95% CI (1.05, 1.50), Z=2.48, P=0.01), It plays a role in reducing anal systolic pressure (MD=15.56, 95% CI (8.59, 22.53), Z=4.38, P<0.0001), but it has no statistical significance in reducing anal resting pressure (MD=-1.25, 95% CI (-15.75, 13.25), Z=0.17, P=0.87), It also played a very good role in reducing anxiety score (MD=-5.04, 95% CI (-7.16, -2.92), Z=4.66, P<0.00001) and depression score (MD=-5.85, 95% CI (-7.93, -3.77), Z=5.52, P<0.00001), and had a greater advantage in reducing follow-up recurrence rate (RR=0.39, 95% CI (0.25, 0.60), Z=4.27, P<0.0001). In terms of adverse reactions, there was no significant difference between the treatment group and the observation group (P=1.00). Conclusion: TCM syndrome differentiation and treatment combined with biofeedback has more advantages than conventional biofeedback treatment.
- Open Access
- 1 January 2023
- Published by Clausius Scientific Press, Inc. in MEDS Chinese Medicine
- Vol. 5 (4) , 50-63
Meta-analysis of the regulatory effect of traditional Chinese medicine on intestinal flora in patients with constipation
Objective: To systematically evaluate the regulatory effect of traditional Chinese medicine on intestinal flora in patients with constipation. Methods: From PubMed, Embase, Web of Science and Cochrane Library to December 2022, the qualified research was screened in strict accordance with the nanofiltration standard. The Cochrane bias risk assessment method and the modified Jadad scale were used to evaluate the quality of literature, and the meta-analysis was carried out using stata 15.0 software. Results: 16 clinical randomized controlled trials were finally included, with a total of 1099 patients. Meta-analysis shows that Chinese medicine can effectively promote bifidobacteria (SMD=0.95, 95% CI (0.78-1.12), Z=10.79, P=0.0000.05), and cocci ratio (SMD=1.32, 95% CI (-0.22,1.16), Z=1.92, P=0.186>0.05). In addition, traditional Chinese medicine can reduce the intestinal PH value of constipation patients (SMD=-0.85, 95% CI (-1.11, -0.59), Z=6.38, P=0.000<0.05), and keep the intestinal micro-ecological environment in balance. Conclusion: Compared with western medicine, traditional Chinese medicine has more advantages in regulating intestinal flora of constipation patients.
- 1 January 2023
- Published by Clausius Scientific Press, Inc. in MEDS Chinese Medicine
- Vol. 5 (4) , 50-63
Open AccessMeta-analysis of the regulatory effect of traditional Chinese medicine on intestinal flora in patients with constipation
Objective: To systematically evaluate the regulatory effect of traditional Chinese medicine on intestinal flora in patients with constipation. Methods: From PubMed, Embase, Web of Science and Cochrane Library to December 2022, the qualified research was screened in strict accordance with the nanofiltration standard. The Cochrane bias risk assessment method and the modified Jadad scale were used to evaluate the quality of literature, and the meta-analysis was carried out using stata 15.0 software. Results: 16 clinical randomized controlled trials were finally included, with a total of 1099 patients. Meta-analysis shows that Chinese medicine can effectively promote bifidobacteria (SMD=0.95, 95% CI (0.78-1.12), Z=10.79, P=0.0000.05), and cocci ratio (SMD=1.32, 95% CI (-0.22,1.16), Z=1.92, P=0.186>0.05). In addition, traditional Chinese medicine can reduce the intestinal PH value of constipation patients (SMD=-0.85, 95% CI (-1.11, -0.59), Z=6.38, P=0.000<0.05), and keep the intestinal micro-ecological environment in balance. Conclusion: Compared with western medicine, traditional Chinese medicine has more advantages in regulating intestinal flora of constipation patients.
- 27 May 2022
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 37 (7) , 1467-1483
Local resection versus radical resection for early-stage rectal cancer: a systematic review and meta-analysis
Purpose The optimal surgical approach for early-stage rectal cancer remains controversial. Radical resection is considered to be the gold standard for rectal cancer treatment. More and more studies show that local resection can replace traditional radical resection in the treatment of early rectal cancer. This research aimed to compare the efficacy of local excision and radical surgery for early-stage rectal cancer and report the evidence-based clinical advantages of both techniques. Methods The clinical trials comparing oncological and perioperative local and radical resection outcomes for early-stage rectal cancer were searched from 7 national and international databases. Results Finally, 3 randomized controlled trials and 14 cohort studies were included. In terms of oncology and perioperative outcomes, there were no statistically significant differences between the radical resection group and the local resection group in terms of OS (HR = 1.05, 95% CI (0.98, 1.13), DFS [HR = 1.18, 95% CI (0.93, 1.48), p = 0.168), distant metastasis rate (RR = 1.04, 95% CI (0.49, 2.20), p = 0.928), and mortality rate (RR = 1.52, 95% CI (0.80, 2.91), p = 0.200). However, there were significant differences in the outcomes of complications (RR = 2.85, 95% CI (2.07, 3.92), p < 0.001), length of hospital stays (WMD = 5.41, 95% CI (3.94, 6.87), p < 0.001), stoma rate (RR = 7.69, 95% CI (2.39, 24.77), p = 0.001), local recurrence rate (RR = 0.48, 95% CI (0.27, 0.86), p = 0.013), operative time (WMD = 74.68, 95% CI (68.00, 81.36), p < 0.001), blood loss (WMD = 156.36, 95% CI (95.48, 217.21, p < 0.001), and adverse events (RR = 1.59, 95% CI (1.05, 2.41), p = 0.027). Conclusion Local excision may be a viable alternative to radical resection for early-stage rectal cancer, but higher quality clinical studies are needed to confirm this.
- 27 May 2022
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 37 (7) , 1467-1483
Local resection versus radical resection for early-stage rectal cancer: a systematic review and meta-analysis
Purpose The optimal surgical approach for early-stage rectal cancer remains controversial. Radical resection is considered to be the gold standard for rectal cancer treatment. More and more studies show that local resection can replace traditional radical resection in the treatment of early rectal cancer. This research aimed to compare the efficacy of local excision and radical surgery for early-stage rectal cancer and report the evidence-based clinical advantages of both techniques. Methods The clinical trials comparing oncological and perioperative local and radical resection outcomes for early-stage rectal cancer were searched from 7 national and international databases. Results Finally, 3 randomized controlled trials and 14 cohort studies were included. In terms of oncology and perioperative outcomes, there were no statistically significant differences between the radical resection group and the local resection group in terms of OS (HR = 1.05, 95% CI (0.98, 1.13), DFS [HR = 1.18, 95% CI (0.93, 1.48), p = 0.168), distant metastasis rate (RR = 1.04, 95% CI (0.49, 2.20), p = 0.928), and mortality rate (RR = 1.52, 95% CI (0.80, 2.91), p = 0.200). However, there were significant differences in the outcomes of complications (RR = 2.85, 95% CI (2.07, 3.92), p < 0.001), length of hospital stays (WMD = 5.41, 95% CI (3.94, 6.87), p < 0.001), stoma rate (RR = 7.69, 95% CI (2.39, 24.77), p = 0.001), local recurrence rate (RR = 0.48, 95% CI (0.27, 0.86), p = 0.013), operative time (WMD = 74.68, 95% CI (68.00, 81.36), p < 0.001), blood loss (WMD = 156.36, 95% CI (95.48, 217.21, p < 0.001), and adverse events (RR = 1.59, 95% CI (1.05, 2.41), p = 0.027). Conclusion Local excision may be a viable alternative to radical resection for early-stage rectal cancer, but higher quality clinical studies are needed to confirm this.